Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€62.80
23.03.20
€70.00
23.03.20
-5.86%
23.03.20

Wirecard AG

Start price
Target price
Perf. (%)
€83.80
23.03.20
€73.00
24.03.20
12.29%
24.03.20

Probably not worthwhile Investment
Revenue decline > 20% expected
Very low/no dividend yield expected
very negative Cash Flow expected
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€1.35
22.03.20
€4.00
04.11.21
123.70%
05.11.21

Could be worthwhile Investment >10% per year
buy
Clorox Co.

Start price
Target price
Perf. (%)
€158.02
22.03.20
-
29.03.20
0.61%
29.03.20

buy
Wirecard AG ADR

Start price
Target price
Perf. (%)
€42.40
22.03.20
€88.00
13.05.20
-1.89%
13.05.20

buy
Danaher Corp.

Start price
Target price
Perf. (%)
€130.00
22.03.20
€150.00
23.03.20
-11.57%
23.03.20

buy
Siemens AG

Start price
Target price
Perf. (%)
€64.99
21.03.20
€92.00
23.03.20
5.17%
23.03.20

Well known brand
High dividend yield expected
buy
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€9.75
21.03.20
€20.00
04.04.20
-55.28%
04.04.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.00
21.03.20
-
04.04.20
3.16%
04.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Sonoma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.80
21.03.20
€12.00
01.06.20
38.79%
01.06.20

buy
Alibaba Group Holding Ltd.

Start price
Target price
Perf. (%)
€20.80
21.03.20
€33.00
04.11.21
-14.82%
31.08.21

buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€81.00
21.03.20
€288.00
29.10.24
25.68%
27.02.24

buy
StoneCo Ltd

Start price
Target price
Perf. (%)
€21.20
20.03.20
€38.00
04.04.20
-17.69%
04.04.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Higher risks for its business
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€35.99
20.03.20
€41.50
04.11.21
33.34%
05.11.21

Could be worthwhile Investment >10% per year
buy
Prosus N.V.

Start price
Target price
Perf. (%)
€54.20
20.03.20
€80.00
04.11.21
38.56%
05.11.21

Could be worthwhile Investment >10% per year
Deutsche Bank AG

Start price
Target price
Perf. (%)
€5.60
20.03.20
€3.62
04.11.21
68.62%
28.11.20

Probably not worthwhile Investment
buy
Avis Budget Group

Start price
Target price
Perf. (%)
€8.85
19.03.20
€75.00
04.11.21
2542.37%
05.11.21

Could be worthwhile Investment >10% per year
buy
Oracle Corp.

Start price
Target price
Perf. (%)
€43.94
19.03.20
€52.20
04.11.21
87.98%
05.11.21

buy
Sixt SE ST

Start price
Target price
Perf. (%)
€38.00
19.03.20
€60.00
25.03.20
53.82%
25.03.20

EBIT growth >5% per year expected
Top Rating
Very valuable balance sheet
Normal challenges to pay loans and raise capital
buy
1&1 Drillisch AG

Start price
Target price
Perf. (%)
€16.69
19.03.20
€29.00
04.11.21
54.46%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.81
19.03.20
€85.00
19.03.20
-3.91%
19.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Siemens Healthineers AG

Start price
Target price
Perf. (%)
€35.55
19.03.20
€44.00
09.04.20
3.19%
09.04.20

Commerzbank AG

Start price
Target price
Perf. (%)
€3.30
19.03.20
€1.77
04.11.21
62.67%
28.11.20

buy
Helmerich & Payne Inc

Start price
Target price
Perf. (%)
€12.40
19.03.20
€23.00
31.03.20
16.13%
31.03.20

buy
Roche Holding AG

Start price
Target price
Perf. (%)
€246.00
19.03.20
€300.00
20.03.20
-
20.03.20